Skip to content Skip to footer
Catalyst Health Ventures
1 800 458 56 97
Investor Portal
Investor Portal
Close

Portfolio

Investing in exceptional teams and companies shaping the future of healthcare
Acquired by:
Veracyte, Inc. (NASDAQ: VCYT)
Acquired by:
Veracyte, Inc. (NASDAQ: VCYT)
ARIA CV
Atacor Medical
Acquired by:
Boston Scientific (NYSE: BSX)
Acquired by:
Boston Scientific (NYSE: BSX)
Avive
Acquired by:
Agilent Technologies (NYSE: A)
Acquired by:
Agilent Technologies (NYSE: A)
Acquired by:
Life Technologies (NYSE: TMO)
Acquired by:
Life Technologies (NYSE: TMO)
Brixton
Conformal
Epitel
Esperto Medical
Eyecool
Acquired by:
ASX: GID
Acquired by:
ASX: GID
Instylla
Acquired by:
Sun Life Financial (NYSE: SLF)
Acquired by:
Sun Life Financial (NYSE: SLF)
Acquired by:
Boston Scientific (NYSE: BSX)
Acquired by:
Boston Scientific (NYSE: BSX)
Panther
Rejoni
Acquired by:
Fortune 500 Company
Acquired by:
Fortune 500 Company
Acquired by:
NASDAQ: SERA
Acquired by:
NASDAQ: SERA
Acquired by:
Medline Systems
Acquired by:
Medline Systems
Venova
Acquired by:
AngioDynamics (NASDAQ: ANGO)
Acquired by:
AngioDynamics (NASDAQ: ANGO)

Featured News

Stay up to date with the latest investments, insights and industry developments

PanTher Completes First Cohort in Pancreatic Cancer Phase 1b Trial Ahead of Expectations

PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage company redefining cancer treatment with therapeutics administered

Have a game-changing idea or looking to collaborate?

Let’s Start the Conversation

Connect